Cargando…
Existence of HbF Enhancer Haplotypes at HBS1L-MYB Intergenic Region in Transfusion-Dependent Saudi β-Thalassemia Patients
Background and Objectives. β-Thalassemia and sickle cell disease are genetic disorders characterized by reduced and abnormal β-globin chain production, respectively. The elevation of fetal hemoglobin (HbF) can ameliorate the severity of these disorders. In sickle cell disease patients, the HbF level...
Autores principales: | Cyrus, Cyril, Vatte, Chittibabu, Borgio, J. Francis, Al-Rubaish, Abdullah, Chathoth, Shahanas, Nasserullah, Zaki A., Jarrash, Sana Al, Sulaiman, Ahmed, Qutub, Hatem, Alsaleem, Hassan, Alzahrani, Alhusain J., Steinberg, Martin H., Ali, Amein K. Al |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322420/ https://www.ncbi.nlm.nih.gov/pubmed/28280727 http://dx.doi.org/10.1155/2017/1972429 |
Ejemplares similares
-
miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia
por: Cyrus, Cyril, et al.
Publicado: (2022) -
Haemoglobin switching modulator SNPs rs5006884 is associated with increased HbA(2) in β-thalassaemia carriers
por: Cyrus, Cyril, et al.
Publicado: (2019) -
Novel Haplotype Indicator for End-Stage Renal Disease Progression among Saudi Patients
por: Cyrus, Cyril, et al.
Publicado: (2019) -
Assessing known chronic kidney disease associated genetic variants in Saudi Arabian populations
por: Cyrus, Cyril, et al.
Publicado: (2018) -
Epstein-Barr virus infection mediated TP53 and Bcl-2 expression in nasopharyngeal carcinoma pathogenesis
por: Vatte, Chittibabu, et al.
Publicado: (2021)